Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Biomarker Discovery Outsourcing Services Industry Expected To Reach By 2029, Starting From 2025 Levels?
The biomarker discovery outsourcing services market has experienced substantial expansion in recent times. Projections indicate it will increase from $14.58 billion in 2024 to $16.96 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 16.3%. Historically, this expansion has stemmed from factors such as a rising disease burden, the demand for pharmaceutical research and development, the prevailing regulatory environment, the availability of cost-effective solutions, enhanced research collaboration, and global integration.
The biomarker discovery outsourcing services market is projected to experience substantial expansion in the coming years. This market is forecast to reach $30.13 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 15.4%. Key factors driving this growth during the projected period include the broadening of personalized medicine, the incorporation of AI and machine learning, the advancement of precision oncology, the provision of biomarker validation services, supportive regulatory frameworks, the increasing need for targeted therapies, and a focus on patient-centric healthcare. Significant trends anticipated for the forecast period encompass a greater uptake of precision medicine, continuous technological innovations, a growing requirement for companion diagnostics, an enlarging scope of drug development pipelines, the emergence of applications in less conventional disease areas, the integration of artificial intelligence (AI) and machine learning (ML), strengthened regulatory backing and standardization efforts, a widening global market presence, strategic partnerships and collaborative ventures, and an emphasis on achieving cost-effectiveness and enhancing time efficiency.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15741&type=smp
Which Factors And Drivers Are Influencing The Biomarker Discovery Outsourcing Services Market In 2025?
An increasing emphasis on personalized medicine is anticipated to drive the expansion of the biomarker discovery outsourcing services market in the future. Personalized medicine refers to healthcare that customizes medical treatment to the individual characteristics of each patient. Its emergence stems from individual genetic, lifestyle, and environmental elements, leading to precise healthcare outcomes that ultimately enhance patient care and minimize adverse effects. The outsourcing of biomarker discovery services helps advance personalized medicine by offering tailored diagnostic and therapeutic solutions, which are developed using individual patients’ biological markers. For instance, data from a February 2024 report by the US-based Personalized Medicine Coalition indicates that in 2023, the FDA sanctioned 16 new personalized treatments for rare disease patients, a significant rise from six in 2022. These newly approved personalized treatments in 2023 comprised seven cancer drugs and three for other diseases and conditions. Consequently, this heightened attention on personalized medicine fuels the growth of biomarker discovery outsourcing services.
What Are The Primary Types Of Segments Analyzed In The Biomarker Discovery Outsourcing Services Market?
The biomarker discovery outsourcing servicesmarket covered in this report is segmented –
1) By Type: Predictive Biomarkers; Prognostic Biomarkers; Safety Biomarkers; Surrogate Endpoints
2) By Discovery Phase: Biomarker Identification; Biomarker Validation; Biomarker Profiling; Biomarker Panel Development; Biomarker Selection
3) By Therapeutic Area: Oncology; Cardiology; Neurology; Autoimmune Diseases; Other Therapeutic Areas
4) By End Use: Pharmaceutical Companies; Biotechnology Companies
Subsegments:
1) By Predictive Biomarkers: Disease Risk Assessment; Therapy Response Prediction; Personalized Medicine Guidance
2) By Prognostic Biomarkers: Disease Progression Prediction; Patient Survival Forecast; Recurrence Risk Assessment
3) By Safety Biomarkers: Toxicity Prediction; Drug Safety Evaluation; Adverse Effect Risk Assessment
4) By Surrogate Endpoints: Clinical Trial Outcome Indicators; Disease Progression Monitoring; Therapy Efficacy Tracking
What Trends Are Redefining The Biomarker Discovery Outsourcing Services Market Dynamics?
Key companies operating in the biomarker discovery outsourcing services market are prioritizing the creation of multiplexed biomarker assays, such as the immunoproteomic discovery platform, to enhance patient outcomes and progress the field of biomarker discovery. An immunoproteomic discovery platform constitutes a specialized system that merges immunology and proteomics to identify and analyze proteins connected to the immune response. For example, in October 2023, Sengenics Corporation LLC, a Singapore-based precision medicine company, unveiled its immunoproteomic discovery platform, a comprehensive protein microarray platform for examining autoantibodies associated with disease diagnosis and therapeutic intervention. The i-Ome Discovery platform was designed to advance immune biomarker discovery and development, offering support to academic and clinical biopharmaceutical research teams aiming for a better understanding of the dynamic interactions and relationships among proteins, the immune system, and disease.
Who Are The Primary Competitors In The Global Biomarker Discovery Outsourcing Services Market?
Major companies operating in the biomarker discovery outsourcing services market are Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC, Crown Bioscience Inc.
Download The Full Report For Exclusive Market Findings:
What Regional Growth Trends Are Shaping The Biomarker Discovery Outsourcing Services Market Outlook?
North America was the largest region in the biomarker discovery outsourcing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker discovery outsourcing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Biomarker Discovery Outsourcing Services Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15741&type=smp
Browse Through More Reports Similar to the Global Biomarker Discovery Outsourcing Services Market 2025, By The Business Research Company
Biolubricants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biolubricants-global-market-report
Biomarkers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
Biofertilizers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biofertilizers-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model